IPO Trending
TATVAEQ / NSE, BSEListed

Tatva Chintan Pharma Chem Limited

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in producing structure directing agents, phase transfer catalysts, pharmaceutical and agrochemical intermediates, and other specialty chemicals, and is among the largest producers of SDAs for zeolites in India. The company caters to a wide range of industries including automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceuticals, personal care, and others, with products sold in India and exported to over 25 countries such as the USA, Germany, South Africa, China, and the UK. Exports contributed around 76% of its revenue in FY 2020, and its customer base includes leading names like Merck, Bayer AG, Laurus Labs, Navin Fluorine, Atul Limited, SRF Limited, and Divi’s Laboratories, with manufacturing facilities located at Ankleshwar and Dahej in Gujarat.

₹1,073 - ₹1,083Open
Listed Price2111.85
Listing Gain+95.00%
Peer Comparison-Financial performance and valuation from the IPO detail feed
Peer comparison data is not available for this IPO yet.